Tracking Blood Vessel Problems After Radiotherapy for Head and Neck Cancer
Follows blood vessel problems in people given radiotherapy for head and neck cancer.
Plain-language title generated from the registry record
Registry title: Long-term Neurovascular Complications After Radiation Therapy in Head and Neck Cancer
Key facts
- Where
- Taipei, TaiwanSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 20 and 100 years old?
Source: NCT06111430, who can take part
Where in Taiwan
- Chang Gung Memorial HospitalTaipei, TaiwanTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Chang Gung Memorial Hospital
- Trial code
- NCT06111430
- Record updated
- 22 October 2026
- Original description
Head and neck cancer is a group of cancers develop from the soft tissues, salivary gland, mucosa of the upper respiratory or digestive system covering the oral and nasal cavity. Radiotherapy is usually the standard treatment of Head and neck cancers. In the present study, investigators aim to study the prevalence of cervical-cranial vascular complications during the early stages in these Head and neck cancer patients receiving Radiotherapy. Investigators will also compare the results between Nasopharyngeal cancer and other Head and neck cancerpatients receiving Radiotherapy.Read full original descriptionShow less
The Ambidirectional Cohort Study of Neurovascular Complications After Radiation Therapy in Head and Neck Cancer Patients
Head and neck cancer is a group of cancers develop from the soft tissues, salivary gland, mucosa of the upper respiratory or digestive system covering the oral and nasal cavity. Radiotherapy is usually the standard treatment of Head and neck cancers. In the present study, investigators aim to study the prevalence of cervical-cranial vascular complications during the early stages in these Head and neck cancer patients receiving Radiotherapy. Investigators will also compare the results between Nasopharyngeal cancer and other Head and neck cancerpatients receiving Radiotherapy.
Inclusion: Age ≥20 years; Head and neck cancer patient ; Had ever received radiation therapy (RT) ≦ 72 months before inclusion in the registry; Had ≥ 1 brain images and cervical-cranial vascular studies between the end of RT and d date of enrolment; Age ≥20 years; Head and neck cancer patient; Had ever received radiation therapy (RT) > 120 months before the adoption date of IRB at the participant site; Had ≥ 2 brain images and cervical-cranial vascular studies between the end of RT and 6~10 years after RT, one within 5 years after RT, the other after 5 years after RT.
Exclusion: Age <20 years; 1.Age <20 years; Patients not willing to sign the informed consent; Population: Retrospective validation cohort.
Population: Prospective cohort.